|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI
|
|
2
|
Zhao J, Mao Z, Fedewa SA, Nogueira L,
Yabroff KR, Jemal A and Han X: The affordable care act and access
to care across the cancer control continuum: A review at 10 years.
CA Cancer J Clin. 70:165–181. 2020.PubMed/NCBI
|
|
3
|
Noone AM, Cronin KA, Altekruse SF,
Howlader N, Lewis DR, Petkov VI and Penberthy L: Cancer incidence
and survival trends by subtype using data from the surveillance
epidemiology and end results program, 1992–2013. Cancer Epidemiol
Biomarkers Prev. 26:632–641. 2017.PubMed/NCBI
|
|
4
|
Singh M and Jadhav HR: Targeting non-small
cell lung cancer with small-molecule EGFR tyrosine kinase
inhibitors. Drug Discov Today. 23:745–753. 2018.PubMed/NCBI
|
|
5
|
Hill A, Gupta R, Zhao D, Vankina R, Amanam
I and Salgia R: Targeted therapies in non-small-cell lung cancer.
Cancer Treat Res. 178:3–43. 2019.PubMed/NCBI
|
|
6
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013.PubMed/NCBI
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI
|
|
8
|
Hauptman N and Glavac D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013.PubMed/NCBI
|
|
9
|
Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q and
Dong D: lncRNADisease 2.0: An updated database of long non-coding
RNA-associated diseases. Nucleic Acids Res. 47:D1034–D1037.
2019.PubMed/NCBI
|
|
10
|
Han S, Cao D, Sha J, Zhu X and Chen D:
lncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by
interacting with UPF1 to destabilize ZFPM2. Mol Oncol.
14:1074–1088. 2020.PubMed/NCBI
|
|
11
|
Yang S, Liu T, Sun Y and Liang X: The long
noncoding RNA LINC00483 promotes lung adenocarcinoma progression by
sponging miR-204-3p. Cell Mol Biol Lett. 24:702019.PubMed/NCBI
|
|
12
|
Zhao M, Xin XF, Zhang JY, Dai W, Lv TF and
Song Y: lncRNA GMDS-AS1 inhibits lung adenocarcinoma development by
regulating miR-96-5p/CYLD signaling. Cancer Med. 9:1196–1208.
2020.PubMed/NCBI
|
|
13
|
Han L, Kong R, Yin DD, Zhang EB, Xu TP, De
W and Shu YQ: Low expression of long noncoding RNA GAS6-AS1
predicts a poor prognosis in patients with NSCLC. Med Oncol.
30:6942013.PubMed/NCBI
|
|
14
|
Luo Z, Han Z, Shou F, Li Y and Chen Y:
LINC00958 accelerates cell proliferation and migration in non-small
cell lung cancer through JNK/c-JUN signaling. Hum Gene Ther
Methods. 30:226–234. 2019.PubMed/NCBI
|
|
15
|
Zhang Y, Fang Z, Guo X, Dong H, Zhou K,
Huang Z and Xiao Z: lncRNA B4GALT1-AS1 promotes colon cancer cell
stemness and migration by recruiting YAP to the nucleus and
enhancing YAP transcriptional activity. J Cell Physiol.
234:18524–18534. 2019.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI
|
|
17
|
Liu C, Yang Z, Deng Z, Zhou Y, Gong Q,
Zhao R and Chen T: Downregulated miR-30e contributes to progression
of lung adenocarcinoma through elevating the expression of SOX9.
Cancer Med. 7:5554–5566. 2018.PubMed/NCBI
|
|
18
|
Chu F, Xue L and Miao H: Long noncoding
RNA TP73-AS1 in human cancers. Clin Chim Acta. 500:104–108.
2020.PubMed/NCBI
|
|
19
|
Gourvest M, Brousset P and Bousquet M:
Long noncoding RNAs in acute myeloid leukemia: Functional
characterization and clinical relevance. Cancers (Basel).
11:16382019.
|
|
20
|
Lu T, Wang Y, Chen D, Liu J and Jiao W:
Potential clinical application of lncRNAs in non-small cell lung
cancer. Onco Targets Ther. 11:8045–8052. 2018.PubMed/NCBI
|
|
21
|
Abdollahzadeh R, Daraei A, Mansoori Y,
Sepahvand M, Amoli MM and Tavakkoly-Bazzaz J: Competing endogenous
RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A
new look at hallmarks of breast cancer. J Cell Physiol.
234:10080–10100. 2019.PubMed/NCBI
|
|
22
|
Wang X, Ju Y, Zhou MI, Liu X and Zhou C:
Upregulation of SOX9 promotes cell proliferation, migration and
invasion in lung adenocarcinoma. Oncol Lett. 10:990–994.
2015.PubMed/NCBI
|
|
23
|
Wang X, Liu Y, Liu X, Yang J, Teng G,
Zhang L and Zhou C: miR-124 inhibits cell proliferation, migration
and invasion by directly targeting SOX9 in lung adenocarcinoma.
Oncol Rep. 35:3115–3121. 2016.PubMed/NCBI
|
|
24
|
Zhang YJ, Xu F, Zhang YJ, Li HB, Han JC
and Li L: miR-206 inhibits non small cell lung cancer cell
proliferation and invasion by targeting SOX9. Int J Clin Exp Med.
8:9107–9113. 2015.PubMed/NCBI
|
|
25
|
miR-32 functions as a tumor suppressor and
directly targets SOX9 in human non-small cell lung cancer
[Retraction]. Onco Targets Ther. 9:63792016.PubMed/NCBI
|
